TCL Archive FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs November 1, 1991
TCL Archive Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent September 30, 2011
TCL Archive Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.” October 29, 2004
TCL Archive NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition February 21, 2014
